The Application Status of Metabolic and Bariatric Surgery for Obese OSAS

doi:10.3877/cma.j.issn.1674-3946.2018.06.028

Abstract

Abstract:

Obesity is the most important reversible risk factor for OSAS, and 40 percent of obese patients suffer from OSAS, while 70 percent of OSAS patients are obese .In the treatment of OSAS, the 2013 version of the United States in OSAS specification guidelines point out that it is strongly recommended fat weight reduction treatment to patients with OSAS, now metabolic and bariatric surgery for obesity is an unique and effective treatment sustaining a long time , which not only treat obesity, obesity complications, but also has significant curative effect, among them the recovery rate of OSAS is as high as 84%, the remission rate is 86% . metabolic and bariatric surgery has just introduced the field of OSAS, but the mechanism of treatment of obesity with OSAS is not clear, the choice of surgical indications and surgical methods is not uniform, so, the metabolism of weight loss surgery application status for the treatment of OSAS was summarized.

Key words: Obesity, Sleep Apnea, Obstructive, Bariatric Surgery

Ainiwaer Adili, Aili Aikebaier. The Application Status of Metabolic and Bariatric Surgery for Obese OSAS[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2018, 12(06): 538-540.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhpwkssxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3946.2018.06.028

https://zhpwkssxzz.cma-cmc.com.cn/EN/Y2018/V12/I06/538

References 31

[1]	Yang R, Barouch LA.Leptin signaling and obesity：cardiovascular consequences[J]．Circ Res, 2007, 101(6):545-559.
[2]	Qaseem A, Holty JE, Owens DK, et al.Management of obstructive sleep apnea in aults：a clinical practice guide line from the American college of physicians[J]．Annals of Internal Medicine, 2013, 159(7):471-483.
[3]	郑成竹，丁丹．肥胖症及代谢疾病的外科手术治疗[J]．中国实用外科杂志，2010，30(3):173-175.
[4]	Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery：a systematic review and meta－analysis[J]. JAMA, 2004, 292(14):1724-1737.
[5]	Collop NA. Obstructive sleep apnea syndromes[J]. Semin Respir Crit Care Med, 2005, 26(1):13-24.
[6]	中华医学会呼吸病学分会. 阻塞性睡眠呼吸暂停低通气综合征诊治指南(2011年修订版)[J]. 中华结核和呼吸杂志，2012, 35(1):9-12.
[7]	Sharkey KM, Machan JT, Tosi C, et al.Predicting obstructive sleep apnea among women candidates forbariatric surgery[J]. J Woment Health, 2010, 19(10):1833-1841.
[8]	Peppard PE, Young T, Palta M, et al.Longitudinal study of moderate weight change and sleep－disordered breathing[J]. JAMA 2000, 284(23):3015-3021.
[9]	Sharkey KM, Orff HJ, Tosi C, et al.Subjectivesleepiness and daytime functioning in bariatric patients with obstructivesleep apnea[J]. Sleep Breath, 2013, 17(1):267-274.
[10]	Dixon JB, Schachter LM, O’Brien PE.Polysomnography before and afterweight loss in obese patients with severe sleep apnea[J]. Int J Obes, 2005, 29(9):1048-1054.
[11]	杨珵璨，王文越，王兵. 减重代谢手术治疗肥胖合并OSAHS[J]. 临床耳鼻咽喉头颈外科杂志，2016，30(6):434-437.
[12]	杨家盛，杜秀芳. 肥胖对阻塞性睡眠呼吸暂停低通气综合征的影响[M]. 中国处方药，2017，13(1) ：1-3.
[13]	金光明，王玮，康健，等. 阻塞性睡眠呼吸暂停患者血清瘦素水平的研究[J]. 中华呼吸与结核杂志，2002，25(4):204-206.
[14]	Ashrafian H, le Roux CW, Rowland SP, et al. Metabolic surgery and obstructive sleep apnoea: the protective effects of bariatric procedures[J]. Thorax, 2012, 67(5):442-449.
[15]	Nijhuis J, van Dielen FM, Buurman WA, et al. Ghrelin, leptin and insulin levels afterrestrictive surgery: a 2－year follow－up study[J]. Obes Surg, 2004, 14(6):783-787.
[16]	Spruyt K, Sans Capdevila O, Serpero LD, et al. Dietary and physical activity patternsin children with obstructive sleep apnea[J]. J Pediatr, 2010, 156(5):724-730.
[17]	Takahashi K, Chin K, Akamizu T, et al. Acylated ghrelin level in patients with OSAbefore and after nasal CPAP treatment[J]. Respirology, 2008, 13(6):810-816.
[18]	Hiestand DM, Britz P, Goldman M, et al. Prevalence of symptoms and risk of sleepapnea in the US population: results from the national sleep foundation sleep inAmerica 2005 poll[J]. Chest, 2006, 130(3):780-786.
[19]	Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Elevation of plasma cytokines indisorders of excessive daytime sleepiness: role of sleep disturbance and obesity[J]．J Clin Endocrinol Metab, 1997, 82(5):1313-1316.
[20]	Punjabi NM, Beamer BA. C－reactive protein is associated with sleep disorderedbreathing independent of adiposity[J]. Sleep, 2007, 30(1):29-34.
[21]	Smith PL, Gold AR, Meyers DA, et al. Weight loss in mildly to moderately obesepatients with obstructive sleep apnea[J]. Ann Intern Med, 1985, 103(6(Pt 1)):850-855.
[22]	刘金钢，郑成竹．中国肥胖和2型糖尿病外科治疗指南(2014)[J]．中国实用科杂志，2014，34(11):1005-1010.
[23]	Caples SM, Gami AS, Somers VK. Obstructive sleep apnea [J]. Annals of Internal Medicine, 2005, 142(3): 187-197.
[24]	Sarkhosh K, Switzer NJ, El－Hadi M, et al. The Impact of Bariatric Surgery on Obstructive Sleep Apnea: A Systematic Review[J][. Obesity Surgery, 2013, 23(3):414-423.
[25]	Santos S, Caramujo C, Silva M, etal.Impact of bariatric surgery on OSAS in obese individuals [J]．Sleep Medicine, 2013, 14(Suppl 1):e273-e273.
[26]	杨埕璨，顾岩，王兵. 减重手术治疗阻塞性睡眠呼吸暂停低通气综合征注意要点[J]. 中国实用外科杂志，2014，34(11):1097-1098.
[27]	中华医学会外科学分会内分泌外科学组，中华医学会外科学分会胃肠外科学组，中华医学会外科学分会外科手术学学组，等. 中国糖尿病外科治疗专家指导意见(2010)[J]. 中国实用外科杂志，2011，31(1): 54-58.
[28]	Aguiar IC, Freitas WR Jr, Santos IR, et al. Obstructive sleep apnea and pulmonary function in patients with severe obesity before and after bariatric surgery: a randomized clinical trial[J]. Multidisciplinary Respiratory Medicine, 2014, 9(1):43-43.
[29]	Foster GD, Borradaile KE, Sanders MH, et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study[J]. Arch Intern Med, 2009, 169(17):1619-1626.
[30]	Johansson K, Neovius M, Lagerros YT, et al. Effect of a very low energy diet on moderate and severe obstructive sleepapnoea in obese men: a randomised controlled trial[J]. BMJ, 2009, 339:b4609-b4609.
[31]	Tuomilehto HP, Seppa¨ JM, Partinen MM, et al. Lifestyle intervention with weight reduction: first－line treatment in mild obstructive sleep apnea[J]. Am J Respir Crit Care Med, 2009, 179(4):320-327.

Please choose a citation manager

Content to export